Health groups sue FDA for Gilead hepatitis C drug trial data
June 29, 2015 at 14:46 PM EDT
June 29 (Reuters) - The U.S. Food and Drug Administration was sued by two advocacy groups seeking to force the faster disclosure of clinical trial data that helped Gilead Sciences Inc win approval for two blockbuster hepatitis C drugs.